MicroRNA Profiles in Triple Negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Epirubicin|DRUG: Cyclophosphamide|DRUG: Paclitaxel|DRUG: Carboplatin
Sponsor: University College Hospital, Ibadan
Collaborators: Lagos State University|Obafemi Awolowo University Teaching Hospital|University of Chicago|University of Lagos, Nigeria|University of Ibadan